Home > Medical Reference > Patient Education

Services at Maryland General

A complete list of inpatient and outpatient healthcare services at MGH.

Chronic fatigue syndrome

Description

An in-depth report on the causes, diagnosis, and treatment of chronic fatigue syndrome.


Highlights

Risk Factors

The CDC now estimates 1 million people have CFS. This may be the tip of the iceberg, since only an estimated 20% of persons with the disease have been diagnosed.

Stress has been identified as a possible trigger of CFS in people who are genetically at risk for the syndrome.

A phenomenon called central sensitization is now suspected to be the connection between fibromyalgia and CFS, which share many of the same features.

Causes

According to the CDC, the first credible evidence that CFS might have a biologic basis comes from 14 studies published in the April 2006 issue of Pharmacogenomics. Twenty researchers in different fields using the same data set independently linked CFS with genes involved with the hypothalamus-pituitary-adrenal axis and the sympathetic nervous system. These genes control the body's response to trauma, injury, and other stressful events.

Diagnosis

Although no definitive test for CFS has been identified, a variety of diagnostic tests are showing promise. One uses mass spectronomy to identify suspected biomarkers of CFS. Another is aimed at identifying gene sequences unique to people with CFS. One test has succeeded in identifying certain compounds in the urine of people with CFS; one has found antibodies to the Epstein-Barr virus as well as markers of oxidative stress; another has associated shrinking gray matter in the brain with CFS. It is hoped that one or more of these tests will prove useful in diagnosing this elusive disease.

Medications

Progress has been made in finding effective medications for CFS. Recent studies have verified the value of antidepressants, particularly SSRIs, D-ribose, and antibiotics, in reducing fatigue and other symptoms of CFS. Studies of a new drug made from dsRNA have shown it to be useful in improving the ability of people with CFS to exercise. This drug is now under FDA review.


  • Review Date: 1/4/2007
  • Reviewed By: Harvey Simon, MD, Editor-in-Chief, Associate Professor of Medicine, Harvard Medical School; Physician, Massachusetts General Hospital
A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org). URAC's accreditation program is the first of its kind, requiring compliance with 53 standards of quality and accountability, verified by independent audit. A.D.A.M. is among the first to achieve this important distinction for online health information and services. Learn more about A.D.A.M.'s editorial process . A.D.A.M. is also a founding member of Hi-Ethics (www.hiethics.com) and subscribes to the principles of the Health on the Net Foundation (www.hon.ch).

The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed medical professional should be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for all medical emergencies. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. © 1997-2007 A.D.A.M., Inc. Any duplication or distribution of the information contained herein is strictly prohibited.
adam.com
     
Physician Directory

Physician Specialties

Medical Glossary

Guide for Patients

Guide for Visitors

    
About Us     ·     Contact Us     ·     Phone Listing     ·     Residency Programs     ·     Site Map     ·     Site Search     ·     Links     ·     FAQs

© 2008 Maryland General Hospital, All Rights Reserved   ·   827 Linden Avenue,   Baltimore, MD 21201   ·   410-225-8000
Commitment to Compliance   ·   Privacy Policy   ·   Terms and Conditions of Use   ·   Disclaimer   ·   JCAHO Public Notice